Copyright
©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Feb 28, 2014; 20(8): 1910-1922
Published online Feb 28, 2014. doi: 10.3748/wjg.v20.i8.1910
Published online Feb 28, 2014. doi: 10.3748/wjg.v20.i8.1910
No. | Regimen | Dosing | Frequency | Adjuvant | Palliative |
1 | 5-FU/LV | Leucovorin 400 mg/m2 IV over 2 h before 5-FU on day 1 | Every 2 wk | Y | Y |
5-FU 400 mg/m2 IV bolus on day 1, followed by 2400 mg/m2 IV over 46 h | |||||
2 | Capecitabine | Capecitabine 1000-1250 mg/m2 by mouth twice daily for 2 wk, then 1 wk off | Every 3 wk | Y | Y |
3 | FOLFOX | Leucovorin 400 mg/m2 IV over 2 h before 5-FU on day 1 | Every 2 wk | Y | Y |
5-FU 400 mg/m2 IV bolus on day 1, followed by 2400 mg/m2 IV over 46 h | |||||
Oxaliplatin 85 mg/m2 IV on day 1 | |||||
4 | CAPOX | Capecitabine 850-1000 mg/m2 by mouth twice daily for 2 wk, then 1 wk off | Every 3 wk | Y | Y |
Oxaliplatin 130 mg/m2 IV on day 1 | |||||
5 | FOLFIRI | Leucovorin 400 mg/m2 IV over 2 h before 5-FU on day 1 | Every 2 wk | N | Y |
5-FU 400 mg/m2 IV bolus on day 1, followed by 2400 mg/m2 IV over 46 h | |||||
Irinotecan 180 mg/m2 IV over 90 min on day 1 | |||||
6 | FOLFOX + Bevacizumab | Leucovorin 400 mg/m2 IV over 2 h before 5-FU on day 1 | Every 2 wk | N | Y |
5-FU 400 mg/m2 IV bolus on day 1, followed by 2400 mg/m2 IV over 46 h | |||||
Oxaliplatin 85 mg/m2 IV on day 1 | |||||
Bevacizumab 5 mg/kg IV on day 1 | |||||
7 | FOLFIRI + Bevacizumab | Leucovorin 400 mg/m2 IV over 2 h before 5-FU on day 1 | Every 2 wk | N | Y |
5-FU 400 mg/m2 IV bolus on day 1, followed by 2400 mg/m2 IV over 46 h | |||||
Irinotecan 180 mg/m2 IV over 90 min on day 1 | |||||
Bevacizumab 5 mg/kg IV on day 1 | |||||
8 | CAPOX + Bevacizumab | Capecitabine 850-1000 mg/m2 by mouth twice daily for 2 wk, then 1 wk off | Every 3 wk | N | Y |
Oxaliplatin 130 mg/m2 IV on day 1 | |||||
Bevacizumab 7.5 mg/kg IV on day 1 | |||||
9 | Capecitabine + Bevacizumab | Capecitabine 850-1000 mg/m2 by mouth twice daily for 2 wk, then 1 wk off | Every 3 wk | N | Y |
Bevacizumab 7.5 mg/kg IV on day 1 | |||||
10 | 5-FU/LV + Bevacizumab | Leucovorin 400 mg/m2 IV over 2 h before 5-FU on day 1 | Every 2 wk | N | Y |
5-FU 400 mg/m2 IV bolus on day 1, followed by 2400 mg/m2 IV over 46 h | |||||
Bevacizumab 5 mg/kg IV on day 1 | |||||
11 | FOLFIRI + Cetuximab | Leucovorin 400 mg/m2 IV over 2 h before 5-FU on day 1 | Every 2 wk | N | Y |
5-FU 400 mg/m2 IV bolus on day 1, followed by 2400 mg/m2 IV over 46 h | |||||
Irinotecan 180 mg/m2 IV over 90 min on day 1 | |||||
Cetuximab 400 mg/m2 IV loading on treatment day 1, then 250 mg/m2 IV every week | |||||
12 | FOLFIRI + Ablifercept | Leucovorin 400 mg/m2 IV over 2 h before 5-FU on day 1 | Every 2 wk | N | Y |
5-FU 400 mg/m2 IV bolus on day 1, followed by 2400 mg/m2 IV over 46 h | |||||
Irinotecan 180 mg/m2 IV over 90 min on day 1 | |||||
Aflibercept 4 mg/kg, over 1 h on day 1 | |||||
13 | Panitumumab | Panitumumab 6 mg/kg IV | Every 2 wk | N | Y |
14 | Regorafenib | Regorafenib 160 mg by mouth once daily for 3 wk, then 1 wk off | Every 4 wk | N | Y |
- Citation: Kurniali PC, Hrinczenko B, Al-Janadi A. Management of locally advanced and metastatic colon cancer in elderly patients. World J Gastroenterol 2014; 20(8): 1910-1922
- URL: https://www.wjgnet.com/1007-9327/full/v20/i8/1910.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i8.1910